Abbott India Ltd. Sees -3.0% Decline in Stock Price on November 13, Rated as 'Hold' by MarketsMOJO
Abbott India Ltd., a leading pharmaceutical and healthcare company in India, saw a -3.0% decline in its stock price on November 13, 2024. The stock has underperformed the sector by -1.06% and has been on a consecutive fall for the last 2 days. Despite this, the stock remains higher than its 200 day moving average, indicating a mixed trend. It has also underperformed the market in both 1 day and 1 month performance. As a responsible news source, we provide this information for informational purposes only and do not make any recommendations or predictions about the company's future potential.
Abbott India ., a leading pharmaceutical and healthcare company in India, has seen a decline of -3.0% in its stock price on November 13, 2024. This has been reflected in the stock call given by MarketsMOJO, which has rated the stock as 'Hold'.
The stock has underperformed the sector by -1.06% on the same day. It has also been on a consecutive fall for the last 2 days, with a decline of -2.81% in this period. The stock touched an intraday low of Rs 27858.05, showing a decrease of -2.62%.
In terms of moving averages, the stock is currently higher than its 200 day moving average, but lower than its 5 day, 20 day, 50 day, and 100 day moving averages. This indicates a mixed trend in the stock's performance.
Comparing the 1 day and 1 month performance of Abbott India Ltd. with the Sensex, we can see that the stock has underperformed the market. While the stock's 1 day performance is -3.10%, the Sensex has only seen a decline of -0.79%. Similarly, the stock's 1 month performance is -3.76%, while the Sensex has seen a decline of -4.09%.
Despite the recent decline in stock price, Abbott India . remains a largecap company in the pharmaceutical and drugs industry. As a responsible and neutral news source, we provide this information for informational purposes only and do not make any recommendations or predictions about the future potential of the company. We strive to provide fact-based reporting to keep our readers informed about the latest developments in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
